Velneperit
Phase IIb One Year Efficacy and Safety Study of S-2367 in Obese Subjects With Initial 6-Week Low Calorie Diet
Shionogi · Phase 2 · Completed · Enrollment 842
| Arm | Nausea | Vomiting | Diarrhea | Discontinuation | Deaths |
|---|---|---|---|---|---|
| Placebo | n/r | n/r | n/r | n/r | n/r |
| S-2367 1600 mg q.d. 54 weeks | n/r | n/r | n/r | n/r | n/r |
| S-2367 1600 mg q.d. 60 weeks | n/r | n/r | n/r | n/r | n/r |
A count stays a count. This page does not turn a count into a percent.